Members of the Hematologic Malignancies Program at Rutgers Cancer Institute of New Jersey examined the utilization of a low dose of oral vancomycin, a drug used at higher doses to treat established Clostridium difficile infection (CDI), as a way to prevent CDI in blood and bone marrow transplant (BMT) patients.
Category: Research Results
White blood cells may cause tumor cell death – but that’s not necessarily a good thing
White blood cells are part of many immune system responses in the human body. New research shows that a specific type of those cells may cause brain cancer tissues to die – but that’s not good news, according to researchers at Penn State College of Medicine and Penn State Cancer Institute.
Researchers Say We’re Watching The World Go Blind
Three University of Michigan researchers say eye care accessibility around the globe isn’t keeping up with an aging population, posing challenges for eye care professionals over the next 30 years.
Are people healthy enough to retire later?
Many people are enjoying longer, healthier lives, but current retirement ages are posing challenges for both policymakers and retirees. A new study looked into whether there is potential to increase the retirement age.
Stunning Discovery Reveals Bonefish Dive 450 Feet ‘Deep’ into the Abyss to Spawn
Using active acoustic telemetry and sonar data, a study provides the first detailed documentation of a shallow water fish diving 450 feet deep to spawn. Prior research has shown that bonefish dive about 164 feet to spawn, but this new and unprecedented study reveals that they reached depths of 450 feet, and moved below 325 feet for two hours before spawning in a rush upward to 220 feet deep.
NUS computer scientists show robot vacuum cleaners can be used by hackers to spy on private conversations
By analysing minute vibrations on common items caused by sound waves, a potential attacker can use a robot vacuum cleaner to retrieve audio data and capture private and sensitive information
Genetic variants linked to heart health in African American childhood cancer survivors
Scientists at St. Jude Children’s Research Hospital have identified genetic variants in African American childhood cancer survivors that have implications for up-front care and long-term surveillance.
Roswell Park Leukemia Chief Shares Promising Findings on New Treatment Options at ASH 2020
Today, during the ASH Annual Meeting and Exposition, Eunice Wang, MD, Chief of Leukemia and Director of Infusion Services at Roswell Park Comprehensive Cancer Center, is presenting data on two ongoing studies incorporating new treatment options for AML.
Analyzing Outcomes of Older Patients with Primary Central Nervous System Lymphoma
Older individuals are at an increased risk of developing primary central nervous system lymphoma (PCNSL). In a retrospective study of patients with newly diagnosed PCNSL, researchers at Rutgers Cancer Institute of New Jersey and colleagues used geriatric assessments to analyze detailed characteristics, treatment, and outcomes in patients across 17 academic centers.
Environmental Surface Testing in Inpatient and Outpatient Hematology/Oncology Settings Shows Negligible Detection of SARS-CoV2
Researchers from Rutgers Cancer Institute of New Jersey evaluated the frequency of SARS-CoV-2, the virus that causes COVID-19, on various environmental surfaces in outpatient and inpatient hematology/oncology settings located within Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility. The study revealed extremely low detection of SARS-CoV-2 on environmental surfaces across multiple outpatient and inpatient oncology areas, including an active COVID-19 floor.
New Biomarker Identifies Patients with Aggressive Lymphoma Who Don’t Respond to Precision Therapy
A new biomarker discovered by a team that includes researchers from Penn Medicine identifies patients with an aggressive form of lymphoma unlikely to respond to the targeted treatment ibrutinib.
التصدي للتحرش الجنسي يتطلب التزامًا مؤسسيًا وثقافة قائمة على القيم
لا يُعد التحرش الجنسي ظاهرة جديدة أو نادرة في مكان العمل، ولكن منذ بدأت حركة #MeToo (#أنا_أيضًا) في أواخر عام 2017 تقدم المزيد من الضحايا للإبلاغ عن اتهامات بالتحرش في مكان العمل، ومنها مؤسسات الرعاية الصحية.
解决性骚扰需要制度性承诺、价值观驱动的文化
性骚扰在工作场所并不新奇或罕见,但自2017年底#MeToo运动开始以来,更多的受害者挺身而出,举报工作场所(包括医疗机构)中的骚扰行为。
Lidar com o assédio sexual requer compromisso institucional e cultura voltada para valores
O assédio sexual não é um fenômeno novo ou raro no local de trabalho, mas desde o início do movimento #MeToo (#EuTambém) no final de 2017, mais vítimas se apresentaram para relatar alegações de assédio no trabalho, inclusive em instituições de saúde.
SARS-CoV-2 in wastewater solids could help monitor COVID-19 spread
Researchers reporting in ACS’ Environmental Science & Technology have discovered that measuring SARS-CoV-2 in settled solids from sewage treatment plants could be a more sensitive approach than measuring the virus in wastewater flowing into the facilities.
Huddles — Not Electronic Communication — May Be the Best Way for Hospital Workers to Cope with Information Glut During COVID-19
Brief “huddles” — rather than a barrage of emails and texts about safety and risk — may be the fastest and simplest way for hospital workers to avoid communication overload as they deal with the flood of COVID-19 cases, a Baylor University researcher says.
Novel form of Alzheimer’s protein found in spinal fluid indicates stage of the disease
Researchers at Washington University School of Medicine in St. Louis have found a novel form of the Alzheimer’s protein tau in the fluid surrounding the brain and spinal cord. This form of tau — known as MTBR tau — indicates what stage of Alzheimer’s a person is in and tracks with tangles of tau protein in the brain.
CRISPR-edited CAR T Cells Enhance Fight Against Blood Cancers
Knocking out a protein known to stifle T cell activation on CAR T cells using the CRISPR/Cas9 technology enhanced the engineered T cells’ ability to eliminate blood cancers.
CAR T cell therapy effective as first-line treatment for high-risk large B-cell lymphoma
A study led by researchers at The University of Texas MD Anderson Cancer Center found that axi-cel, an autologous anti-CD19 chimeric antigen receptor (CAR) T cell therapy, is a safe and effective first-line therapy for patients with high-risk large B-cell lymphoma (LBCL), a group with an urgent need for new and effective treatments.
Venetoclax added to standard treatments shows promise in high-risk myeloid blood cancers
The novel oral drug venetoclax can be safely added to standard therapies for some high-risk myeloid blood cancers and in early studies the combination shows promise of improved outcomes, say scientists from Dana-Farber Cancer Institute.
Off-the-Shelf Immune Drug Shows Promise in Aggressive Multiple Myeloma
A subcutaneous injection of the immune-boosting drug teclistamab was found to be safe and elicit responses in a majority of patients with relapsed or refractory multiple myeloma.
CAR T-cell therapy found highly effective in patients with high-risk non-Hodgkin lymphoma
A CAR T-cell therapy known as axicabtagene ciloleucel (axi-cel) drove cancer cells to undetectable levels in nearly 80% of patients with advanced non-Hodgkin lymphoma (NHL) in a phase 2 clinical trial, Dana-Farber Cancer Institute investigators report at the virtual 62nd American Society of Hematology (ASH) Annual Meeting.
Study reveals surprising benefit of clonal hematopoiesis in allogeneic transplants
Clonal hematopoiesis (CH) is a recently identified condition in which mutations associated with blood cancers are detected in the blood of some healthy, usually older, individuals who don’t have cancer. People with CH, while asymptomatic, have an elevated risk of developing blood cancers and other negative health outcomes, including heart attacks and strokes.
Changes Needed to Address Financial Hardship from Cancer
Until you or a loved one are facing treatment for a cancer diagnosis, you may not realize the cost associated with treatment and doctor visits.
EMBARGOED STUDY: Potential Cancer Therapy May Boost Immune Response
A new approach to cancer therapy shows potential to transform the commonly used chemotherapy drug gemcitabine into a drug that kills cancer cells in a specialized way, activating immune cells to fight the cancer, according to a study led by Cedars-Sinai Cancer investigators.
New Study Finds Once Hospitalized, Black Patients with COVID-19 Have Lower Risk of Death than White Patients
A team of investigators at NYU Langone Health has found that once hospitalized, Black patients (after controlling for other serious health conditions and neighborhood income) were less likely to have severe illness, die, or be discharged to hospice compared to White patients.
Virtual Doctor Visits are Increasing, but Use Differs by Patient Race, Age and Insurance, Study Finds
A new study out of UChicago Medicine published December 4, 2020, in the journal JMIR Medical Informatics examines the increase in telemedicine visits due to the COVID-19 pandemic and recommends adopting policies that encourage virtual visits going forward.
Multiomics, Gentational Cd Exposure, Estrogen Receptor Transactivation, and More Featured in December 2020 Toxicological Sciences
The December 2020 issue of the Society of Toxicology’s official journal, Toxicological Sciences, delivers cutting-edge toxicological research in endocrine toxicology, environmental toxicology, organ-specific toxicology, and more.
Properties vs. chemistry: Co-Optima research determines accurate predictor of fuel performance, develops roadmap for designing biofuels
As ORNL’s fuel properties technical lead for the U.S. Department of Energy’s Co-Optimization of Fuel and Engines, or Co-Optima, initiative, Jim Szybist has been on a quest for the past few years to identify the most significant indicators for predicting how a fuel will perform in engines designed for light-duty vehicles such as passenger cars and pickup trucks.
John Theurer Cancer Center (JTCC) Researchers to Present 52 Abstracts across Hematological Malignancies at the 2020 American Society of Hematology (ASH) Annual Meeting and Exposition
Research updates provide a strong focus on CAR-T cell therapy and small molecules to treat the most common blood cancers: leukemia, lymphoma, and myeloma
New pathway in development of Alzheimer’s disease discovered, providing earlier target for potential therapeutics
A novel Alzheimer’s disease marker—coming early in progression of the condition—could open significant new fronts of research into possible therapies
COVID-19 in Victorian schools and childcare mainly driven by community transmission
Analysis of Victorian data by the Murdoch Children’s Research Institute suggests that COVID-19 cases in schools and childcare were mainly driven by community transmission
The Mediterranean diet reduces the risk of having another heart attack
Heart disease is the main cause of death in developed countries.
Researchers discover new particle in the blood of septic patients
Researchers at La Jolla Institute for Immunology (LJI) have found that people with sepsis have never-before-seen particles in their blood. The scientists are the first to show that these particles, called elongated neutrophil-derived structures (ENDS), break off of immune cells and change their shape as they course through the body.
Using a video game to understand the origin of emotions
Emotions are complex phenomena that influence our minds, bodies and behaviour.
Donor stem cell transplant shown to improve survival in older patients with myelodysplastic syndrome
A new clinical trial offers the most compelling evidence to date that a donor stem cell transplant can improve survival rates for older patients with higher-risk myelodysplastic syndrome (MDS), Dana-Farber Cancer Institute investigators report at the virtual 62nd American Society of Hematology (ASH) Annual Meeting.
Identifying markers of COVID-19 infection using blood tests
Researchers from the Institute of Biomedicine of Seville (IBIS) have presented a study carried out in the Clinical Biochemistry Service of the Virgen del Rocío University Hospital which identifies the values for six biochemical biomarkers that indicate a patient may be infected with SARS-COV-2 (COVID-19).
Research confirms crucial monitoring assessment is effective for patients with COVID-19
A combined research team from the Universities of Portsmouth and Bournemouth and Portsmouth Hospitals University NHS Trust has shown that an assessment score used to measure a patient’s severity of illness can be applied to patients with Covid-19 without modification.
Immunity passports: Ethical conflict and opportunity
Immunity passports are a means of registering whether an individual has developed immunity to COVID-19 and is therefore unlikely to either catch or spread the disease.
The climate changed rapidly alongside sea ice decline in the north
Researchers from the Niels Bohr Institute, University of Copenhagen have, in collaboration with Norwegian researchers in the ERC Synergy project, ICE2ICE, shown that abrupt climate change occurred as a result of widespread decrease of sea ice.
Kidney Injury in Diabetic Ketoacidosis Linked to Brain Injury
Researchers have identified factors that make children with diabetic ketoacidosis more likely to experience acute kidney injury. Analyzing data from a large, multicenter clinical trial, the researchers also found that children who experience acute kidney injury are more likely to also experience subtle cognitive impairment and demonstrate lower IQ scores, suggesting a pattern of multiple organ injury.
BIDMC researchers define immune system’s requirements for protection against COVID-19
In a new paper in the journal Nature, BIDMC researchers shed light on the role of antibodies and immune cells in protection against SARS-CoV-2, the virus that causes COVID-19, in rhesus macaques.
NSF’s Inouye Solar Telescope Releases First Image of a Sunspot
The U.S. NSF’s Daniel K. Inouye Solar Telescope just released its first image of a sunspot. The telescope’s four-meter primary mirror will give the best views of the Sun from Earth throughout the next solar cycle. This image is an indication of the telescope’s advanced optics. The image is released along with the first of a series of Inouye-related articles featured in the Solar Physics Journal.
Exploration of Genomic Ancestry in B-Cell Malignancies Identifies Multiple Important Genomic Differences
Investigators from Foundation Medicine, Inc. and Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, examined genomic ancestry in BCL subtypes applying genomic ancestry prediction methodology to comprehensive genomic profiling data and found multiple genomic differences. Results of the study will be shared at the virtual American Society of Hematology Annual Meeting.
DUNE publishes first physics results from prototype detector
Results from the ProtoDUNE single-phase detector at CERN pave the way for detectors 20 times larger for the international Deep Underground Neutrino Experiment, hosted by Fermilab.
Pathways to sustainable land use and food systems
The findings of a new report suggest that integrated strategies across food production, biodiversity, climate, and diets can meet the objectives of the Paris Agreement and the Sustainable Development Goals (SDGs).
Battery of tests: Scientists figure out how to track what happens inside batteries
The new method could be the key to designing more efficient batteries for specific uses, like electric cars and airplanes.
UC San Diego Bolsters Aggressive Return to Learn Plan to Prevent Outbreaks on Campus
UC San Diego’s nationally recognized, evidence-based Return to Learn program employs a comprehensive suite of education, monitoring, testing, intervention and notification tools that no other university is using. And the program continues to expand—including a recent introduction of weekly self-administered student testing kits, growth of the campus’s wastewater viral monitoring program and widespread use of the cellphone-based CA COVID Notify exposure notification system.
Gestational age linked to ADHD in children with Down syndrome
A new study by the UC Davis MIND Institute finds a connection between gestational age and ADHD in children with Down syndrome. An earlier gestational age is linked to higher ADHD symptoms later in childhood.
Researchers discover how bean plants fend off famished foes
A team led by scientists at the University of Washington and the University of California, San Diego has discovered that cowpeas — a type of bean plant — harbor receptors on the surface of their cells that can detect a compound in caterpillar saliva and initiate anti-herbivore defenses.